Medpace Holdings Inc. (MEDP) is a global clinical research organization (CRO) that provides comprehensive clinical research services to pharmaceutical and biotechnology companies. The company offers a range of services to support drug development, including clinical trial design, protocol development, project management, site monitoring, data management, and statistical analysis. Medpace specializes in managing clinical trials for complex and rare diseases, with a focus on oncology, cardiology, and central nervous system disorders. The company operates in more than 45 countries worldwide and has conducted clinical trials in more than 80 countries. Medpace is headquartered in Cincinnati, Ohio, and as of September 2021, had a market capitalization of approximately $6.3 billion.
Medpace Holdings Inc. (MEDP) is a global clinical research organization (CRO) that provides comprehensive clinical research services to pharmaceutical and biotechnology companies. The company offers a range of services to support drug development, including clinical trial design, protocol development, project management, site monitoring, data management, and statistical analysis. Medpace specializes in managing clinical trials for complex and rare diseases, with a focus on oncology, cardiology, and central nervous system disorders. The company operates in more than 45 countries worldwide and has conducted clinical trials in more than 80 countries. Medpace is headquartered in Cincinnati, Ohio, and as of September 2021, had a market capitalization of approximately $6.3 billion.